Mr. Jason Dussault reports

STILLCANNA'S EUROPEAN ACQUISITION SATIVA GROUP ANNOUNCES RECORD SALES FOR JUNE

Stillcanna Inc.'s planned strategic acquisition, the Sativa Group PLC, one of the United Kingdom's first medical cannabis companies, had record sales for the month of June.

In complementing the Goodbody brands already expansive cannabidiol product range with a U.K.-compliant hand sanitizer and a cannabigerol-based hand sanitizer, both Goodbody Botanicals and Goodbody Wellness realized increased sales volumes. By addressing current market opportunities through new product development, record sales have been achieved in the month of June.

Wide ranges of business demographics including restaurants and airlines, hotels groups, and retailers have embraced the Goodbody sanitizer program to safeguard and protect their customers and staff.

Henry Lees-Buckley, chief executive officer of Sativa, said: "Through our corporate customers we have achieved very strong hand sanitizer sales to complement our existing CBD sales, which have resulted in a record month for the group. We're very pleased to reach this milestone during these difficult retail trading conditions."

"Together Stillcanna and the Sativa Group address many vertical markets within the cannabis landscape," stated Jason Dussault, CEO of Stillcanna. "The combined entities strengths, industry knowledge and wide product range have resulted in a record month for the group in one of the most challenging times in the market. As a combined corporate group, we look forward to continued growth in the new normal."

About Stillcanna Inc.

Stillcanna is a Canadian early-stage life sciences company focused on the large-scale manufacturing of CBD in Europe. The company believes its proprietary intellectual property allows it to extract CBD at a lower cost.

We seek Safe Harbor.